← FDA Drug Approvals (Drugs@FDA)

DOBUTAMINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1995-02-16

Drug application

FDA Application #
ANDA074292
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOBUTAMINE HYDROCHLORIDE
Generic name
Dobutamine Hydrochloride
Active ingredients
DOBUTAMINE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
HOSPIRA
First approval
1995-02-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown